assessmentsCompare.compareTheTopMental

assessmentsCompare.choosingTheRightAssessment assessmentsCompare.fullAssessmentLibraryassessmentsCompare.learnAbout assessmentsCompare.primaryCareWorkflowsassessmentsCompare.andDiscoverThe assessmentsCompare.hiqIntelligenceEngine.

assessmentsCompare.assessment assessmentsCompare.comparisonGuide

assessmentsCompare.chooseTheRightValidated

assessmentsCompare.depressionScreeningTools

assessmentsCompare.assessmentassessmentsCompare.itemsassessmentsCompare.timeassessmentsCompare.scoringassessmentsCompare.bestForassessmentsCompare.strengths
PHQ-9
Patient Health Questionnaire-9
92-3 min
0-27 scale
Mild: 5-9, Moderate: 10-14, Severe: 15+
Primary care screening, treatment monitoring
  • • Criterion standard
  • • DSM-5-TR aligned
  • • Quick
  • • Widely validated
PHQ-2
Patient Health Questionnaire-2
2< 1 min
0-6 scale
Positive screen: 3+
Quick screening, follow with PHQ-9 if positive
  • • Extremely brief
  • • High sensitivity
  • • Good for busy clinics
BDI-II
Beck Depression Inventory II
215-10 min
0-63 scale
Mild: 14-19, Moderate: 20-28, Severe: 29+
In-depth assessment, specialist settings
  • • Thorough
  • • Research standard
  • • Cognitive symptoms

assessmentsCompare.anxietyScreeningTools

assessmentsCompare.assessmentassessmentsCompare.itemsassessmentsCompare.timeassessmentsCompare.scoringassessmentsCompare.bestForassessmentsCompare.strengths
GAD-7
Generalized Anxiety Disorder-7
72-3 min
0-21 scale
Mild: 5-9, Moderate: 10-14, Severe: 15+
Primary care, generalized anxiety screening
  • • Criterion standard
  • • Quick
  • • Good sensitivity/specificity
GAD-2
Generalized Anxiety Disorder-2
2< 1 min
0-6 scale
Positive screen: 3+
Ultra-brief screening, follow with GAD-7
  • • Extremely brief
  • • High sensitivity
  • • Initial screen
BAI
Beck Anxiety Inventory
215-10 min
0-63 scale
Mild: 8-15, Moderate: 16-25, Severe: 26+
Detailed anxiety assessment, somatic symptoms
  • • Thorough
  • • Physical symptoms
  • • Research validated

assessmentsCompare.ptsdScreeningTools

assessmentsCompare.assessmentassessmentsCompare.itemsassessmentsCompare.timeassessmentsCompare.scoringassessmentsCompare.bestForassessmentsCompare.strengths
PCL-5
PTSD Checklist for DSM-5-TR
205-10 min
0-80 scale
Positive screen: 33+, Symptom clusters tracked
PTSD screening and monitoring, DSM-5-TR aligned
  • • Current criterion standard
  • • DSM-5-TR criteria
  • • Cluster scores
PC-PTSD-5
Primary Care PTSD Screen
5< 2 min
0-5 scale
Positive screen: 3+
Quick primary care screening
  • • Very brief
  • • High sensitivity
  • • Follow with PCL-5
LEC-5
Life Events Checklist + Criterion A
17 + Criterion A5-10 min
Trauma exposure assessment
Exposure inventory, not diagnostic
Trauma history, pairs with PCL-5
  • • Thorough trauma history
  • • DSM-5-TR Criterion A

assessmentsCompare.substanceUseScreeningTools

assessmentsCompare.assessmentassessmentsCompare.itemsassessmentsCompare.timeassessmentsCompare.scoringassessmentsCompare.bestForassessmentsCompare.strengths
AUDIT
Alcohol Use Disorders Identification Test
102-4 min
0-40 scale
Hazardous: 8+, Harmful: 16+, Dependent: 20+
Alcohol use screening in any setting
  • • World Health Organization validated
  • • Widely used
  • • Detects early problems
DAST-10
Drug Abuse Screening Test
102-4 min
0-10 scale
Low: 1-2, Moderate: 3-5, Severe: 6+
Drug use screening (not alcohol)
  • • Brief
  • • All drug types
  • • Good reliability
ASSIST
Alcohol, Smoking and Substance Involvement Screening Test
8 per substance5-10 min
Substance-specific risk scores
Low, Moderate, High risk per substance
Thorough multi-substance screening
  • • Multiple substances
  • • World Health Organization validated
  • • Risk stratification

assessmentsCompare.clinicalDecisionGuide

Primary Care: 15-Minute Appointments

Need quick, validated screening without extending appointment time

assessmentsCompare.recommended
PHQ-2 + GAD-2 as initial screen. If positive, send full PHQ-9 + GAD-7 for completion before next visit.

Intake: New Client Assessment

Thorough baseline assessment for treatment planning

assessmentsCompare.recommended
PHQ-9, GAD-7, PCL-5, and relevant substance use screens (AUDIT/DAST-10). Provides full diagnostic picture.

Treatment Monitoring

Track progress bi-weekly during active treatment

assessmentsCompare.recommended
Same tools as baseline (usually PHQ-9 + GAD-7). Consistency enables progress graphs and outcome measurement.

Specialized Assessment

Client presenting with complex trauma history

assessmentsCompare.recommended
Start with LEC-5 (trauma inventory), follow with PCL-5, add DASS-21 for comorbid depression/anxiety assessment.

assessmentsCompare.accessValidatedAssessments

assessmentsCompare.hiboopProvidesAccessTo